Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 1, 1997
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
N Herrmann, K L Lanctôt
International Journal of Geriatric Psychiatry
|
April 18, 2000
Donepezil for behavioural disorders associated with Lewy bodies: a case series
K L Lanctôt, N Herrmann
Clinical Pharmacology and Therapeutics
|
December 1, 1995
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events
K L Lanctôt, C A Naranjo
Journal of Clinical Pharmacology
|
February 1, 1994
Computer-assisted evaluation of adverse events using a Bayesian approach
K L Lanctôt, C A Naranjo
Journal of the American Geriatrics Society
|
August 26, 1998
Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients
J H Moss, K L Lanctôt
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 24, 2001
Role of serotonin in the behavioral and psychological symptoms of dementia
K L Lanctôt, N Herrmann, P Mazzotta
Current Drug Targets
|
September 25, 2010
Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
A B Gold, N Herrmann, K L Lanctôt
Journal of Medical Economics
|
September 29, 2012
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence
J M Hussman, K L Lanctôt, B Paes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 1, 1989
Benzodiazepine use and abuse in Canada
U Busto, K L Lanctôt, P Isaac, et al.
Journal of Clinical Pharmacology
|
February 1, 1993
Comparative study on benzodiazepine use in Canada and Chile
I Ruiz, J Offermanns, K L Lanctôt, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
June 1, 1997
From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia
N Herrmann, K L Lanctôt
International Journal of Geriatric Psychiatry
|
April 18, 2000
Donepezil for behavioural disorders associated with Lewy bodies: a case series
K L Lanctôt, N Herrmann
Clinical Pharmacology and Therapeutics
|
December 1, 1995
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events
K L Lanctôt, C A Naranjo
Journal of Clinical Pharmacology
|
February 1, 1994
Computer-assisted evaluation of adverse events using a Bayesian approach
K L Lanctôt, C A Naranjo
Journal of the American Geriatrics Society
|
August 26, 1998
Iatrogenic benzodiazepine withdrawal delirium in hospitalized older patients
J H Moss, K L Lanctôt
The Journal of Neuropsychiatry and Clinical Neurosciences
|
February 24, 2001
Role of serotonin in the behavioral and psychological symptoms of dementia
K L Lanctôt, N Herrmann, P Mazzotta
Current Drug Targets
|
September 25, 2010
Lithium and its neuroprotective and neurotrophic effects: potential treatment for post-ischemic stroke sequelae
A B Gold, N Herrmann, K L Lanctôt
Journal of Medical Economics
|
September 29, 2012
The cost effectiveness of palivizumab in congenital heart disease: a review of the current evidence
J M Hussman, K L Lanctôt, B Paes
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 1, 1989
Benzodiazepine use and abuse in Canada
U Busto, K L Lanctôt, P Isaac, et al.
Journal of Clinical Pharmacology
|
February 1, 1993
Comparative study on benzodiazepine use in Canada and Chile
I Ruiz, J Offermanns, K L Lanctôt, et al.
Page
of 4